Document is current
Any future updates will be listed below
-
Authors
Mahmoud, Sara A.
Elkhoely, Abeer
El-Sayed, Elsayed K.
Ahmed, Amany A. E.
-
Funding
Funding for this research was provided by:
Helwan University
- License Information
-
More Information
Article History
Received: 22 November 2023
Accepted: 23 February 2024
First Online: 5 March 2024
Declarations
:
: Animal care and experimental protocols were approved by the animal care and use committee at the Faculty of Pharmacy, Helwan University (Protocol #: 08A2021). All animal handling and procedures were performed according to the Guide for the Care and Use of Laboratory Animals published by the US National Institute of Health (NIH publication No. 85-23, revised 1996).
: The authors declare no competing interests.
: In clinical practice, Pioglitazone and ligustrazine may be taken as a combination therapy in case of type 2 diabetes mellites in which acute gastric inflammation and ulcer disease occur with high prevalence (Amr et al. ), a fact which dictates the study of the protective effect these two drugs against type2 diabetes mellitus-induced acute gastric ulcer.
